跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 109,685 条关于
“ERBB2-positive breast cancer”
全部
109,685
临床试验
85,628
药物
2,363
机构
1,174
资讯
20,520
去年
High TIL Levels Could Enable Shorter Trastuzumab Treatment in Early ERBB2-Positive Breast Cancer
去年
Dendritic Cell Immunotherapy Shows Promise in Early-Stage ERBB2-Positive Breast Cancer
2年前
One-Year Trastuzumab Improves Disease-Free Survival in ERBB2-Positive Breast Cancer
4年前
Margetuximab Not Cost-Effective Compared to Trastuzumab for ERBB2-Positive Advanced Breast Cancer
去年
HER2 Amplification Varies Significantly Across Cancers and Patient Subgroups, Study Finds
2年前
HER2DX® Genomic Test Demonstrates Predictive Value in Advanced HER2+ Breast Cancer
去年
Genomic Profiling of HER2-Low Metastatic Breast Cancer Reveals Potential Therapeutic Strategies
9个月前
REVEAL GENOMICS Unveils Breakthrough CNS Progression Score for HER2+ Breast Cancer Brain Metastasis Prediction at SABCS 2025
去年
HER2DX® Genomic Assay Transforms Treatment Decisions in Early-Stage HER2+ Breast Cancer
去年
Novel HER2-Targeted Therapies Show Promise in Advanced Breast Cancer
第 1 页，共 2052 页
上一页
下一页
